supply agreement between Helius & MediPharm

New Zealand grower to import Canadian medicinal cannabis materials

New Zealand’s largest medicinal cannabis company, Helius Therapeutics Limited, has entered into a supply agreement with GMP-certified cannabinoid wholesalers MediPharm Labs Australia, a subsidiary of MediPharm Labs Corp., to supply a New Zealand-exclusive selection of pharmaceutical-quality (GMP certified) medicinal cannabis materials to Helius.

New Zealand’s Medicinal Cannabis Scheme took effect on 1 April, allowing the industry to move towards commercialisation and to make cannabis-based medicines more accessible to thousands of patients in need. However, Covid-19 has created some delays, particularly as all cannabis facility construction was suspended during lockdown.

Helius says it’s thrilled to be partnering with MediPharm Labs Australia, helping to ensure many suffering Kiwis seeking relief under the Medicinal Cannabis Scheme, are not impacted by Covid-19 related hold-ups. 
 
Paul Manning, Chief Executive Officer, Helius Therapeutics
Chief Executive of Helius Therapeutics, Paul Manning, says this initiative to import THC and CBD cannabis materials from Australia and Canada allows his company to make up lost time before local production facilities come online.

“Our $25m medical cannabis facility in East Auckland is due to be completed later this year. This supply agreement with MediPharm Labs Australia now accelerates our plans to improve the quality of life of thousands of Kiwis. It means Helius can be in a position to serve patients, through healthcare professionals, sooner than anticipated,” he says.

Mr. Manning says Helius expands its offerings in the future to meet evolving patient needs.

The supply agreement, becomes effective upon confirmation from Medsafe that all applicable New Zealand quality and regulatory standards are met.

Local research and cultivation of medicinal cannabis at Helius’ Auckland facility commenced in 2019. The company was among the first to be licensed to cultivate cannabis in New Zealand. Helius also holds a License to Deal and is on track to commence local medicines manufacturing in 2020.

For more information:
Helius
www.helius.co.nz

 

For more information:
MediPharm Labs
151 John Street, Barrie
+1 705 719 7425 
medipharmlabs.com

 


Publication date:



Receive the daily newsletter in your email for free | Click here


Other news in this sector:


© MMJDaily.com 2020

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber